002688 金河生物
按盤價 
5.190 +0.010 (+0.193%)
5.190 +0.010 (+0.193%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.760 | 1.232 | 4.460 | 3.870 | 3.245 |
| 總資產報酬率 ROA (%) | 1.099 | 0.493 | 1.805 | 1.736 | 1.764 |
| 投入資產回報率 ROIC (%) | 1.255 | 0.572 | 2.100 | 2.008 | 2.021 | 邊際利潤分析 |
| 銷售毛利率 (%) | 35.628 | 33.859 | 33.509 | 29.552 | 28.916 |
| 營業利潤率 (%) | 10.362 | 1.476 | 4.157 | 4.817 | 5.712 |
| 息稅前利潤/營業總收入 (%) | 13.869 | 4.571 | 6.947 | 6.876 | 5.940 |
| 淨利潤/營業總收入 (%) | 8.538 | -0.382 | 3.557 | 4.344 | 5.564 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 100.257 | 549.009 | 196.094 | 114.388 | 116.439 |
| 價值變動淨收益/利潤總額(%) | -0.195 | -6.127 | -1.252 | -1.502 | -3.312 |
| 營業外收支淨額/利潤總額(%) | 0.125 | -8.503 | -0.785 | -3.189 | -2.016 | 償債能力分析 |
| 流動比率 (X) | 1.298 | 1.142 | 1.086 | 0.904 | 1.049 |
| 速動比率 (X) | 0.905 | 0.771 | 0.744 | 0.606 | 0.643 |
| 資產負債率 (%) | 57.035 | 55.728 | 55.759 | 53.855 | 46.206 |
| 帶息債務/全部投入資本 (%) | 48.915 | 47.507 | 47.074 | 48.165 | 40.289 |
| 股東權益/帶息債務 (%) | 90.728 | 98.120 | 98.270 | 99.542 | 140.469 |
| 股東權益/負債合計 (%) | 68.872 | 72.454 | 71.304 | 76.496 | 106.646 |
| 利息保障倍數 (X) | 3.970 | 1.424 | 2.462 | 3.115 | 17.426 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 68.237 | 64.628 | 72.993 | 72.212 | 64.638 |
| 存貨周轉天數 (天) | 131.299 | 123.245 | 149.119 | 158.238 | 149.484 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 05/06/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
